Makers Laboratories Limited (MLL), incorporated in 1984 in Maharashtra, specializes in manufacturing pharmaceutical formulations and drug intermediates. Key expansions include increasing tablet and capsule capacity to 60 crore units by 2000 and modernizing its formulation drugs through a rights issue of equity shares. The company has undergone several mergers, including with Makers Drugs & Food Products Ltd. in 1993 and Harleystreet Pharmaceuticals Ltd. in 2011, issuing equity shares to facilitate these amalgamations. Strategic divestments include selling its Palghar unit in 2008 and Dombivili bulk drugs unit in 2016-17.
Recent developments include acquiring a majority stake in Resonance Specialties Limited in 2020, launching new diabetic and hypertensive drugs, and initiating the production of ophthalmic eye drops at Naroda, Ahmedabad in 2021. MLL started upgrading its Naroda liquid injectable manufacturing unit in 2022, highlighting its commitment to capacity expansion and modernization. These strategic decisions reflect MLL's focus on growth and adapting to industry demands.
